In the US, Celecoxib celecoxib systemic is a member of the drug class cox-2 inhibitors and is used to treat Ankylosing Spondylitis, Familial Adenomatous Polyposis, Fibromatosis, Juvenile Rheumatoid Arthritis, Osteoarthritis, Pain, Period Pain, Rheumatoid Arthritis and Spondyloarthritis. FDA Alert 4/7/2005 Celebrex has been associated with an increased risk of serious adverse cardiovascular CV events in a long-term placebo controlled trial. Should you still take Celebrex. Sold only as a prescription, brand-name drug, celecoxib can easily cost $130 or more a month for a standard dose.
Should you still take Celebrex? - Consumer Reports
In January, Public Citizen petitioned to have Bextra and Celebrex, two COX-2 inhibitors, removed from the market because they increase the risk of heart attacks. The FDA is unlikely to ban advertising. Dr. Jenkins said it had no power to do, Harris reports. Whether the FDA will actually make any distinction and come down harder on Vioxx and Bextra than on Celebrex remains to be seen. Among oncologists prescribing a daily dose of COX-2 inhibitor against prostate cancer, Celebrex seems to be preferred to Vioxx.
Nonsteroidal Anti-inflammatory Drugs NSAIDs
Examples of prescription NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. FDA Strengthens Warning of Heart Attack and Stroke Risk for Non-Steroidal. That was when the Food & Drug Administration FDA. While some consumer groups began calling for a Celebrex ban, company officials went on the defensive.